z-logo
Premium
The Donor‐Acceptor‐Acceptor Purine Analog: Transformation of 5‐aza‐7‐deaza‐1 H ‐isoguanine (=4‐aminoimidazo‐[1,2‐ a ]‐1,3,5‐triazin‐2(1 H )‐one) to 2′‐deoxy‐5‐aza‐7‐deaza‐isoguanosine using purine nucleoside phosphorylase
Author(s) -
Voegel Johannes J.,
Altorfer Michael M.,
Benner Steven A.
Publication year - 1993
Publication title -
helvetica chimica acta
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.74
H-Index - 82
eISSN - 1522-2675
pISSN - 0018-019X
DOI - 10.1002/hlca.19930760520
Subject(s) - chemistry , purine nucleoside phosphorylase , yield (engineering) , acceptor , stereochemistry , purine , pyrimidine , purine metabolism , deoxyribonucleoside , derivative (finance) , oligonucleotide , anomer , combinatorial chemistry , enzyme , biochemistry , dna , materials science , physics , economics , financial economics , metallurgy , condensed matter physics
A new synthesis is reported for 4‐aminoimidazo[1,2‐ a ]‐1,3,5‐triazin‐2(1 H )‐one ( =5‐aza‐7‐deaza‐isoguanosine; 8 ), a purine analog that, when incorporated into an oligonucleotide chain, presents a H‐bond donor‐acceptor‐acceptor pattern to a complementary pyrimidine analog. A protected ribose derivative was coupled to 8 to yield 4‐amino‐8‐(β‐ D ‐ribofuranosyl)imidazo[1,2‐ a ]‐1,3,5‐triazin‐2(8 H )‐one ( =5‐aza‐7‐deaza‐isoguanosine; 11 ) after deprotection, Alternatively, direct synthesis of both the ribo derivative 11 and the corresponding deoxyribo derivative 17 as the β‐ D ‐anomers was achieved using the enzyme purine nucleoside phosphorylase in a one‐pot reaction. This adapts a known synthetic approach to yield a new strategy for obtaining diastereoisomerically pure deoxyribonucleoside analogs on 1‐gram scales.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom